REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia
Clinical trial NCT03742323 · TERMINATED
Trial details
- NCT number
- NCT03742323
- Sponsor
- PETHEMA Foundation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2020-06-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.